Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
June 30, 2026 65.26M
March 31, 2026 57.83M
December 31, 2025 71.83M
September 30, 2025 66.30M
June 30, 2025 67.99M
March 31, 2025 69.15M
December 31, 2024 70.90M
September 30, 2024 70.85M
June 30, 2024 70.75M
March 31, 2024 70.64M
December 31, 2023 69.86M
September 30, 2023 69.81M
June 30, 2023 69.76M
March 31, 2023 69.63M
December 31, 2022 68.85M
September 30, 2022 68.81M
June 30, 2022 68.73M
March 31, 2022 68.57M
December 31, 2021 67.74M
September 30, 2021 67.66M
June 30, 2021 67.59M
March 31, 2021 67.43M
December 31, 2020 66.88M
September 30, 2020 66.85M
June 30, 2020 66.81M
Date Value
March 31, 2020 39.75M
December 31, 2019 39.25M
September 30, 2019 39.23M
June 30, 2019 39.04M
March 31, 2019 38.82M
December 31, 2018 38.47M
September 30, 2018 38.46M
June 30, 2018 38.30M
March 31, 2018 38.00M
December 31, 2017 37.76M
September 30, 2017 37.50M
June 30, 2017 37.35M
March 31, 2017 37.08M
December 31, 2016 36.76M
September 30, 2016 36.72M
June 30, 2016 30.39M
March 31, 2016 30.38M
December 31, 2015 30.36M
September 30, 2015 30.36M
June 30, 2015 30.34M
March 31, 2015 30.78M
December 31, 2014 30.78M
September 30, 2014 30.78M
June 30, 2014 30.78M
March 31, 2014 28.73M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Biomerica, Inc. 3.195M
Univec, Inc. 2.523B
Indivior Pharmaceuticals, Inc. 118.00M
Zomedica Corp. 979.95M
Bristol Myers Squibb Co. 2.043B